Literature DB >> 25495756

Profilin1 activity in cerebellar granule neurons is required for radial migration in vivo.

Jan A Kullmann1, Ines Wickertsheim, Lara Minnerup, Mercedes Costell, Eckhard Friauf, Marco B Rust.   

Abstract

Neuron migration defects are an important aspect of human neuropathies. The underlying molecular mechanisms of such migration defects are largely unknown. Actin dynamics has been recognized as an important determinant of neuronal migration, and we recently found that the actin-binding protein profilin1 is relevant for radial migration of cerebellar granule neurons (CGN). As the exploited brain-specific mutants lacked profilin1 in both neurons and glial cells, it remained unknown whether profilin1 activity in CGN is relevant for CGN migration in vivo. To test this, we capitalized on a transgenic mouse line that expresses a tamoxifen-inducible Cre variant in CGN, but no other cerebellar cell type. In these profilin1 mutants, the cell density was elevated in the molecular layer, and ectopic CGN occurred. Moreover, 5-bromo-2'-deoxyuridine tracing experiments revealed impaired CGN radial migration. Hence, our data demonstrate the cell autonomous role of profilin1 activity in CGN for radial migration.

Entities:  

Keywords:  BrdU+, BrdU-positive; BrdU, 5-bromo-2′-deoxyuridine; CGN, cerebellar granule neurons; CaMKIV, Ca2+/calmodulin-dependent protein kinase IV; EGL, external granule cell layer; IGL, internal granule cell layer; ML, molecular layer; Math1-Cre, Math1-mediated Cre expression; NeuN, neuron-specific nuclear protein; P, postnatal day; PI, propidium iodide.; Pfn1, profilin1; actin dynamics; actin treadmilling; actin-binding protein; cerebellar cortex; cerebellar development; cerebellar granule neurons; cerebellum; neuronal migration; profilin; radial migration; βGal+, βGal-positive; βGal, β-galactosidase; βGal−, βGal-negative

Mesh:

Substances:

Year:  2014        PMID: 25495756      PMCID: PMC4594489          DOI: 10.4161/19336918.2014.983804

Source DB:  PubMed          Journal:  Cell Adh Migr        ISSN: 1933-6918            Impact factor:   3.405


  16 in total

1.  Immunological evidence that the beta isoform of Ca2+/calmodulin-dependent protein kinase IV is a cerebellar granule cell-specific product of the CaM kinase IV gene.

Authors:  H Sakagami; M Umemiya; T Kobayashi; S Saito; H Kondo
Journal:  Eur J Neurosci       Date:  1999-07       Impact factor: 3.386

2.  Developmental and cell type-specific expression of the neuronal marker NeuN in the murine cerebellum.

Authors:  Anja Weyer; Karl Schilling
Journal:  J Neurosci Res       Date:  2003-08-01       Impact factor: 4.164

Review 3.  Trekking across the brain: the journey of neuronal migration.

Authors:  Ramsés Ayala; Tianzhi Shu; Li-Huei Tsai
Journal:  Cell       Date:  2007-01-12       Impact factor: 41.582

4.  Generalized lacZ expression with the ROSA26 Cre reporter strain.

Authors:  P Soriano
Journal:  Nat Genet       Date:  1999-01       Impact factor: 38.330

5.  Motility and cytoskeletal organization of migrating cerebellar granule neurons.

Authors:  R J Rivas; M E Hatten
Journal:  J Neurosci       Date:  1995-02       Impact factor: 6.167

6.  Profilin1 is required for glial cell adhesion and radial migration of cerebellar granule neurons.

Authors:  Jan A Kullmann; Alexander Neumeyer; Christine B Gurniak; Eckhard Friauf; Walter Witke; Marco B Rust
Journal:  EMBO Rep       Date:  2011-12-23       Impact factor: 8.807

7.  Inducible Cre recombinase activity in mouse cerebellar granule cell precursors and inner ear hair cells.

Authors:  Lionel M L Chow; Yong Tian; Thomas Weber; Mary Corbett; Jian Zuo; Suzanne J Baker
Journal:  Dev Dyn       Date:  2006-11       Impact factor: 3.780

8.  Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety.

Authors:  F Tronche; C Kellendonk; O Kretz; P Gass; K Anlag; P C Orban; R Bock; R Klein; G Schütz
Journal:  Nat Genet       Date:  1999-09       Impact factor: 38.330

9.  Matrix-binding vascular endothelial growth factor (VEGF) isoforms guide granule cell migration in the cerebellum via VEGF receptor Flk1.

Authors:  Carmen Ruiz de Almodovar; Cathy Coulon; Paul Antoine Salin; Ellen Knevels; Naura Chounlamountri; Koen Poesen; Karlien Hermans; Diether Lambrechts; Katie Van Geyte; Joke Dhondt; Tom Dresselaers; Julie Renaud; Julian Aragones; Serena Zacchigna; Ilse Geudens; David Gall; Stijn Stroobants; Mireille Mutin; Karel Dassonville; Erik Storkebaum; Bénédicte F Jordan; Ulf Eriksson; Lieve Moons; Rudi D'Hooge; Jody J Haigh; Marie-Françoise Belin; Serge Schiffmann; Paul Van Hecke; Bernard Gallez; Stefan Vinckier; Alain Chédotal; Jérôme Honnorat; Nicole Thomasset; Peter Carmeliet; Claire Meissirel
Journal:  J Neurosci       Date:  2010-11-10       Impact factor: 6.167

10.  Purkinje cell loss and motor coordination defects in profilin1 mutant mice.

Authors:  J A Kullmann; A Neumeyer; I Wickertsheim; R T Böttcher; M Costell; J W Deitmer; W Witke; E Friauf; M B Rust
Journal:  Neuroscience       Date:  2012-08-03       Impact factor: 3.590

View more
  3 in total

1.  Developmental Expression of Mutant PFN1 in Motor Neurons Impacts Neuronal Growth and Motor Performance of Young and Adult Mice.

Authors:  Merryn Brettle; Holly Stefen; Aleksandra Djordjevic; Sandra Y Y Fok; Josephine W Chan; Annika van Hummel; Julia van der Hoven; Magdalena Przybyla; Alexander Volkerling; Yazi D Ke; Fabien Delerue; Lars M Ittner; Thomas Fath
Journal:  Front Mol Neurosci       Date:  2019-09-27       Impact factor: 5.639

2.  Transient reduction in dendritic spine density in brain-specific profilin1 mutant mice is associated with behavioral deficits.

Authors:  A Özge Sungur; Caroline Zeitouny; Lea Gabele; Isabell Metz; Markus Wöhr; Kristin Michaelsen-Preusse; Marco B Rust
Journal:  Front Mol Neurosci       Date:  2022-08-03       Impact factor: 6.261

3.  Silencing of Profilin-1 suppresses cell adhesion and tumor growth via predicted alterations in integrin and Ca2+ signaling in T24M-based bladder cancer models.

Authors:  Maria Frantzi; Zoi Klimou; Manousos Makridakis; Jerome Zoidakis; Agnieszka Latosinska; Daniel M Borràs; Bart Janssen; Ioanna Giannopoulou; Vasiliki Lygirou; Andreas C Lazaris; Nicholas P Anagnou; Harald Mischak; Maria G Roubelakis; Antonia Vlahou
Journal:  Oncotarget       Date:  2016-10-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.